CLINICAL_TRIALS
trial_result
· 2014-03-24
Clinical Trial Update: A Study to Evaluate the Effect of Repeat Oral Doses of YM443 on Cardiac Repolarization in Healthy Adults [Phase 1]
Summary
Phase 1 study evaluating the effect of repeat oral doses of YM443 on cardiac repolarization in healthy adults has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Astellas Pharma Inc | Conditions: Functional Dyspepsia | Phase 1 | Status: COMPLETED